Display Options:

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: D2-like dopamine receptor antagonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Pain; Postoperative Nausea and Vomiting; Psychotic Disorders

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacterial Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: HIV Infections; Pneumonia, Bacterial; Endocarditis; Infections; Intraabdominal Infections; Meningitis, Bacterial; Sepsis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alcoholism; Autistic Disorder; Brain Injuries; Carcinoma, Non-Small-Cell Lung; Cerebral Hemorrhage; Child Development Disorders, Pervasive; Cholangitis, Sclerosing; Fibromyalgia; Glioblastoma; Glioma; Hemorrhage; Macular Edema; Memory Disorders; Periapical Periodontitis; Pneumonia; Retinal Vein Occlusion; Skin Diseases; Angelman Syndrome; Asthma; Atrial Fibrillation; Carotid Stenosis; Chronic Pain; Colorectal Neoplasms; Cystic Fibrosis; Depressive Disorder, Major; Esophageal Neoplasms; Fragile X Syndrome; HIV Infections; Head and Neck Neoplasms; Huntington Disease; Impetigo; Lung Neoplasms; Macular Degeneration; Multiple Myeloma; Multiple Sclerosis, Relapsing-Remitting; Neuralgia; Obsessive-Compulsive Disorder; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Parkinson Disease; Retinal Detachment; Retinitis Pigmentosa; Stroke; Amyotrophic Lateral Sclerosis; Arthritis, Rheumatoid; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Heroin Dependence; Hypertension; Idiopathic Pulmonary Fibrosis; Lichen Planus, Oral; Multiple Sclerosis; Neurobehavioral Manifestations; Peri-Implantitis; Periodontitis; Pneumothorax; Psychotic Disorders; Rosacea; Schizophrenia; Spinal Cord Injuries; Acne Vulgaris; Bacterial Infections; Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hyperemia; Neoplasms; Common Cold; Conjunctivitis, Allergic; Influenza, Human; Eye Manifestations; Nasal Obstruction

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mu opioid receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Infections; Bacteremia; Gram-Positive Bacterial Infections; Osteomyelitis; Bacterial Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: HIV Infections; Acquired Immunodeficiency Syndrome; Meningitis; Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Opioid receptors; mu/kappa/delta antagonist
ROUTE OF ADMINISTRATION: INJECTION; INTRAMUSCULAR; NASAL; SUBCUTANEOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Opioid-Related Disorders; Gambling; Constipation; Intestinal Obstruction; Depression; Pain; Shock, Septic

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thymidylate synthase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Astrocytoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Gliosarcoma; Neoplasms; Oligodendroglioma; Intracranial Hypertension; Meningitis, Cryptococcal; Candidiasis; Infections; Meningitis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hepatitis C; Intestinal Obstruction; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Feeding and Eating Disorders; Hypogonadism; Irritable Bowel Syndrome; Neuralgia; Obesity; Pruritus; Chronic Pain; Epilepsy; Heroin Dependence; Low Back Pain; Morphine Dependence; Mycosis Fungoides; Neoplasms; Opioid-Related Disorders; Osteoarthritis; Pain; Parkinson Disease; Restless Legs Syndrome; Sezary Syndrome; Substance Withdrawal Syndrome; Substance-Related Disorders; Constipation

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: DENTAL; INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: DENTISTRY; OTHER
THERAPEUTIC INDICATION: Breast Neoplasms; Acne Vulgaris; Conjunctivitis; Infections; Periodontitis; Psittacosis; Respiratory Tract Infections; Rosacea; Spotted Fever Group Rickettsiosis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Leukemia, Myeloid, Acute; Urinary Bladder, Overactive; Breast Neoplasms; Cellulitis; Dermatitis, Atopic; Eczema; Staphylococcal Infections; Urinary Tract Infections; Cystic Fibrosis; Nasal Obstruction; Skin Diseases; Urinary Bladder Neoplasms; Bacterial Infections; Infections; Otitis Media; Prostatitis; Respiratory Tract Infections; Sprains and Strains

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial DNA-directed RNA polymerase inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Carcinoma, Non-Small-Cell Lung; Constipation; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Endometriosis; Essential Hypertension; HIV Infections; Hepatitis B, Chronic; Hodgkin Disease; Hypertension, Pulmonary; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Mycoses; Nausea; Neoplasms; Non-alcoholic Fatty Liver Disease; Parkinson Disease; Renal Insufficiency; Renal Insufficiency, Chronic; Respiratory Syncytial Virus Infections; Rhinoscleroma; Sepsis; Thrombosis; Acquired Immunodeficiency Syndrome; Buruli Ulcer; Cystic Fibrosis; Meningitis; Multiple Sclerosis; Mycobacterium avium-intracellulare Infection; Onchocerciasis; Sarcoidosis; Alzheimer Disease; Arthritis, Reactive; Diarrhea; Endocarditis; Enterocolitis, Pseudomembranous; Infections; Leprosy; Multiple System Atrophy; Tuberculosis; Tuberculosis, Pulmonary

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Breast Neoplasms; Dermatitis, Atopic; Hemorrhoids; Skin Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial dihydropteroate synthase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bacterial Infections; Eye Infections

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adrenergic receptor alpha agonist
ROUTE OF ADMINISTRATION: OPHTHALMIC
STATUS: Approved
THERAPEUTIC AREA: EYE; OTHER
THERAPEUTIC INDICATION: Inflammation; Influenza, Human; Pterygium; Common Cold; Nasal Obstruction; Rhinitis, Allergic, Seasonal; Sinusitis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Retinoic acid receptor agonist
ROUTE OF ADMINISTRATION: ORAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; OTHER
THERAPEUTIC INDICATION: Amyotrophic Lateral Sclerosis; Hematologic Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Anemia; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Carcinoma, Adenoid Cystic; Cholangitis, Sclerosing; Emphysema; Keratosis, Actinic; Kidney Neoplasms; Lentigo; Lung Neoplasms; Lymphoma; Melanoma; Multiple Myeloma; Neuroblastoma; Pancreatic Neoplasms; Prostatic Neoplasms; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Striae Distensae; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Leukemia; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Myeloproliferative Disorders; Purpura, Thrombocytopenic, Idiopathic; Rosacea; Acne Vulgaris; Hyperpigmentation; Leukemia, Promyelocytic, Acute; Melanosis; Neoplasms

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Progesterone receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Carcinoma in Situ; Dementia; HIV Wasting Syndrome; Head and Neck Neoplasms; Pulmonary Disease, Chronic Obstructive; Uterine Neoplasms; Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Hot Flashes; Liver Neoplasms; Acquired Immunodeficiency Syndrome; Anorexia; Cachexia; Neoplasms; Primary Immunodeficiency Diseases

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Breast Neoplasms; Neuroendocrine Tumors; Psoriasis; Acanthamoeba Keratitis; Melanoma; Tobacco Use Disorder

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: OPHTHALMIC; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Corneal Opacity; Dry Eye Syndromes; Acne Vulgaris; Eye Diseases; Hemorrhoids; Inflammation

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: BUCCAL; IMPLANTATION; INJECTION; NASAL; TRANSDERMAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR; DIABETES DRUGS & ENDOCRINOLOGY; OTHER
THERAPEUTIC INDICATION: Aging; Kallmann Syndrome; Penile Induration; Acquired Immunodeficiency Syndrome; Anorexia Nervosa; Dwarfism; Heart Failure; Hereditary Breast and Ovarian Cancer Syndrome; Menopause; Multiple Sclerosis; Muscular Diseases; Obesity; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcopenia; Spinal Cord Injuries; Testicular Neoplasms; Coronary Disease; Disorders of Sex Development; Erectile Dysfunction; Hip Fractures; Infertility; Metabolic Syndrome; Neoplasms; Renal Insufficiency, Chronic; Sexual Dysfunction, Physiological; Hypogonadism; Klinefelter Syndrome; Orchitis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscarinic acetylcholine receptor M3 agonist
ROUTE OF ADMINISTRATION: INTRAOCULAR
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Presbyopia; Cataract; Glaucoma; Miosis

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alzheimer Disease; Prostatic Neoplasms, Castration-Resistant; Dental Caries; Gingivitis; Sensitivity and Specificity

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: GABA-A receptor; anion channel positive allosteric modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anxiety; Anxiety Disorders; Seizures

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D2 receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Psoriasis; Psychotic Disorders

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel protein type IV alpha subunit blocker
ROUTE OF ADMINISTRATION: INJECTION; SPINAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Chronic Pain; HIV Infections; Hernia, Inguinal; Wounds and Injuries; Cleft Palate; Hallux Valgus; Hemorrhoids; Neoplasms; Osteoarthritis; Peritoneal Neoplasms; Radiculopathy; Anesthesia; Pain

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS; TOPICAL; VAGINAL
STATUS: Approved
THERAPEUTIC AREA: IMMUNE SYSTEM; OTHER; PREGNANCY AND GYNECOLOGY
THERAPEUTIC INDICATION: Rosacea; Vulvovaginitis; Abdominal Abscess; Abscess; Acne Vulgaris; Empyema; Endometritis; Enterocolitis, Pseudomembranous; Genital Diseases, Female; Infections; Intraabdominal Infections; Irritable Bowel Syndrome; Lung Abscess; Osteomyelitis; Parametritis; Peritonitis; Pneumonia; Respiratory Tract Infections; Sepsis; Soft Tissue Infections; Vaginosis, Bacterial

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscle-type nicotinic acetylcholine receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown

MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacterial Infections